🌍January 1, 1970·Jan 1, 1970Industry

bioAffinity Technologies Announces Pricing of $3.2 Million Offering – bioAffinity

Publisher

bioAffinity Technologies

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher: bioAffinity Technologies
Region: 最新
Scope: Industry
Published: January 1, 1970

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on bioaffinitytech.com

Leave the platform to read the original full article on the publisher site.

Source: bioAffinity Technologies

Scope: Industry

Open original article

Related coverage

More related coverage

bioAffinity Technologies/1d ago

Sputum-Based Test May Identify Drug Targets in Asthma and COPD – Patient Care Online

Adial Pharmaceuticals/1d ago

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

Amarin Corporation/2d ago

งานบ้านและสวนแฟร์ Shopping Week 2026 วันที่ 20 – 28 มิถุนายน 2569 เวลา 10.00 – 21. 00 น. ณ ฮอลล์ 8 – 10 อิมแพ็ค เมืองทองธานี

Aptose Biosciences/2d ago

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation